Literature DB >> 25911555

Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A.

Diego Zanolini1, Simone Merlin1, Maria Feola1, Gabriella Ranaldo1, Angela Amoruso1, Gianluca Gaidano2, Mauro Zaffaroni3, Alessandro Ferrero4, Sandra Brunelleschi1, Guido Valente2, Sanjeev Gupta5, Maria Prat1, Antonia Follenzi6.   

Abstract

A large fraction of factor VIII in blood originates from liver sinusoidal endothelial cells although extrahepatic sources also contribute to plasma factor VIII levels. Identification of cell-types other than endothelial cells with the capacity to synthesize and release factor VIII will be helpful for therapeutic approaches in hemophilia A. Recent cell therapy and bone marrow transplantation studies indicated that Küpffer cells, monocytes and mesenchymal stromal cells could synthesize factor VIII in sufficient amount to ameliorate the bleeding phenotype in hemophilic mice. To further establish the role of blood cells in expressing factor VIII, we studied various types of mouse and human hematopoietic cells. We identified factor VIII in cells isolated from peripheral and cord blood, as well as bone marrow. Co-staining for cell type-specific markers verified that factor VIII was expressed in monocytes, macrophages and megakaryocytes. We additionally verified that factor VIII was expressed in liver sinusoidal endothelial cells and endothelial cells elsewhere, e.g., in the spleen, lungs and kidneys. Factor VIII was well expressed in sinusoidal endothelial cells and Küpffer cells isolated from human liver, whereas by comparison isolated human hepatocytes expressed factor VIII at very low levels. After transplantation of CD34(+) human cord blood cells into NOD/SCIDγNull-hemophilia A mice, fluorescence activated cell sorting of peripheral blood showed >40% donor cells engrafted in the majority of mice. In these animals, plasma factor VIII activity 12 weeks after cell transplantation was up to 5% and nine of 12 mice survived after a tail clip-assay. In conclusion, hematopoietic cells, in addition to endothelial cells, express and secrete factor VIII: this information should offer further opportunities for understanding mechanisms of factor VIII synthesis and replenishment. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25911555      PMCID: PMC4486222          DOI: 10.3324/haematol.2014.123117

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  50 in total

1.  Allogeneic bone marrow transplantation in a child with severe aplastic anemia and hemophilia A.

Authors:  M Ostronoff; F Ostronoff; G Campos; S Arruda; C Vaz; R Florencio; R Calixto; A P Souto Maior; A Sucupira; M Domingues; C Tagliari
Journal:  Bone Marrow Transplant       Date:  2006-03       Impact factor: 5.483

2.  Liver tissue engineering at extrahepatic sites in mice as a potential new therapy for genetic liver diseases.

Authors:  Kazuo Ohashi; Jacob M Waugh; Michael D Dake; Takashi Yokoyama; Hiroyuki Kuge; Yoshiyuki Nakajima; Masaki Yamanouchi; Hiroyuki Naka; Akira Yoshioka; Mark A Kay
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

3.  Ten-year experience with living related donated splenic transplantation for the treatment of hemophilia A.

Authors:  H C Jiang; Y Gao; W J Dai; B Sun; J Xu; H Q Qiao; Q H Meng; C J Wu
Journal:  Transplant Proc       Date:  2006-06       Impact factor: 1.066

4.  Efficient expression of a transgene in platelets using simian immunodeficiency virus-based vector harboring glycoprotein Ibalpha promoter: in vivo model for platelet-targeting gene therapy.

Authors:  Tsukasa Ohmori; Jun Mimuro; Katsuhiro Takano; Seiji Madoiwa; Yuji Kashiwakura; Akira Ishiwata; Masanori Niimura; Katsuyuki Mitomo; Toshiaki Tabata; Mamoru Hasegawa; Keiya Ozawa; Yoichi Sakata
Journal:  FASEB J       Date:  2006-05-24       Impact factor: 5.191

5.  Correction of hemophilia as a proof of concept for treatment of monogenic diseases by fetal spleen transplantation.

Authors:  Anna Aronovich; Dalit Tchorsh; Helena Katchman; Smadar Eventov-Friedman; Elias Shezen; Uri Martinowitz; Bruce R Blazar; Sivan Cohen; Orna Tal; Yair Reisner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-05       Impact factor: 11.205

6.  Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies.

Authors:  Qizhen Shi; David A Wilcox; Scot A Fahs; Hartmut Weiler; Clive W Wells; Brian C Cooley; Drashti Desai; Patricia A Morateck; Jack Gorski; Robert R Montgomery
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

7.  FVIII production by human lung microvascular endothelial cells.

Authors:  Marc Jacquemin; Arne Neyrinck; Maria Iris Hermanns; Renaud Lavend'homme; Filip Rega; Jean-Marie Saint-Remy; Kathelijne Peerlinck; Dirk Van Raemdonck; Charles James Kirkpatrick
Journal:  Blood       Date:  2006-03-28       Impact factor: 22.113

8.  Correction of murine hemophilia A by hematopoietic stem cell gene therapy.

Authors:  Morvarid Moayeri; Teresa S Hawley; Robert G Hawley
Journal:  Mol Ther       Date:  2005-10-12       Impact factor: 11.454

9.  Transplantation of endothelial cells corrects the phenotype in hemophilia A mice.

Authors:  V Kumaran; D Benten; A Follenzi; B Joseph; R Sarkar; S Gupta
Journal:  J Thromb Haemost       Date:  2005-09       Impact factor: 5.824

10.  Detection of factor VIII/coagulant antigen in human liver tissue.

Authors:  H V Stel; T H van der Kwast; E C Veerman
Journal:  Nature       Date:  1983 Jun 9-15       Impact factor: 49.962

View more
  16 in total

1.  The search for the origin of factor VIII synthesis and its impact on therapeutic strategies for hemophilia A.

Authors:  Valder R Arruda
Journal:  Haematologica       Date:  2015-07       Impact factor: 9.941

2.  Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A.

Authors:  Cristina Olgasi; Maria Talmon; Simone Merlin; Alessia Cucci; Yvonne Richaud-Patin; Gabriella Ranaldo; Donato Colangelo; Federica Di Scipio; Giovanni N Berta; Chiara Borsotti; Federica Valeri; Francesco Faraldi; Maria Prat; Maria Messina; Piercarla Schinco; Angelo Lombardo; Angel Raya; Antonia Follenzi
Journal:  Stem Cell Reports       Date:  2018-11-08       Impact factor: 7.765

3.  Maternal microchimerism protects hemophilia A patients from inhibitor development.

Authors:  Yeling Lu; Zhenping Chen; Jing Dai; Xi Wu; Hao Gu; Zekun Li; Jian Li; Qiulan Ding; Wenman Wu; Runhui Wu; Xuefeng Wang
Journal:  Blood Adv       Date:  2020-05-12

4.  FVIII expression by its native promoter sustains long-term correction avoiding immune response in hemophilic mice.

Authors:  Simone Merlin; Rosella Famà; Ester Borroni; Diego Zanolini; Valentina Bruscaggin; Silvia Zucchelli; Antonia Follenzi
Journal:  Blood Adv       Date:  2019-03-12

5.  A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice.

Authors:  Simone Merlin; Elvira Stefania Cannizzo; Ester Borroni; Valentina Bruscaggin; Piercarla Schinco; Warut Tulalamba; Marinee K Chuah; Valder R Arruda; Thierry VandenDriessche; Maria Prat; Guido Valente; Antonia Follenzi
Journal:  Mol Ther       Date:  2017-05-26       Impact factor: 11.454

6.  Evidence for CD19B-CD8T cell interactions in blood and tissues from patients with GvHD.

Authors:  S Deola; C Cugno; P Comoli; I Guido; L Rubert; M Zecca; D Zanolini; A Follenzi; M Langes; G Negri; M Tauber; I Pusceddu; I Cavattoni; M Svaldi; G U Grigoleit; E Baumeister; E Wang; S Rutella; F M Marincola
Journal:  Bone Marrow Transplant       Date:  2016-11-07       Impact factor: 5.483

7.  Potential for cellular stress response to hepatic factor VIII expression from AAV vector.

Authors:  Irene Zolotukhin; David M Markusic; Brett Palaschak; Brad E Hoffman; Meera A Srikanthan; Roland W Herzog
Journal:  Mol Ther Methods Clin Dev       Date:  2016-09-28       Impact factor: 6.698

8.  Overexpression of factor VIII after AAV delivery is transiently associated with cellular stress in hemophilia A mice.

Authors:  Amy M Lange; Ekaterina S Altynova; Giang N Nguyen; Denise E Sabatino
Journal:  Mol Ther Methods Clin Dev       Date:  2016-09-28       Impact factor: 6.698

9.  Kupffer Cell Transplantation in Mice for Elucidating Monocyte/Macrophage Biology and for Potential in Cell or Gene Therapy.

Authors:  Simone Merlin; Kuldeep K Bhargava; Gabriella Ranaldo; Diego Zanolini; Christopher J Palestro; Laura Santambrogio; Maria Prat; Antonia Follenzi; Sanjeev Gupta
Journal:  Am J Pathol       Date:  2016-01-07       Impact factor: 4.307

Review 10.  Escape or Fight: Inhibitors in Hemophilia A.

Authors:  Simone Merlin; Antonia Follenzi
Journal:  Front Immunol       Date:  2020-03-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.